| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |